NIH Global Health Funding News - Week of May 6, 2019
On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding
opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates
are typically distributed once a week.
NIH funding opportunities focusing on global health and foreign collaboration.
HIV/AIDS Clinical Trials Units (UM1 Clinical Trial Required) (RFA-AI-19-045)
AIDS Application Due Date: November 18, 2019
NIAID is soliciting applications from domestic and foreign institutions to serve as Clinical Trials Units (CTUs) for NIH HIV/AIDS Clinical Trials Networks. A priority is placed on reaching populations severely impacted by the HIV/AIDS epidemic whose participation will help address priorities for NIH HIV/AIDS research. These populations include, but are not limited to women, adolescents, sexual and gender as well as other minorities, people who inject drugs in the United States, and populations in low and middle-income countries.
NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.
NIH funding opportunities for which United States small business concerns (SBCs) may collaborate with a foreign business entity.
NIH funding news that may be relevant to global health researchers.
- Notice of Change to Eligibility Requirements to the International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed) (NOT-TW-19-004)
- Notice of Intent to Publish a Funding Opportunity Announcement for:
Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed) (NOT-OD-19-100)
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) (NOT-OD-19-104)
- Notice of NICHD Participation in PAR-18-822 "Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)" (NOT-HD-19-010)